World delirium awareness and quality survey in 2023—a worldwide point prevalence study
Weltweite Umfrage zu Delir-Bewusstsein und Qualität 2023 – eine weltweite Punktprävalenzstudie
Age and Ageing · 2024-11-01 · 53 (11)
DOI: 10.1093/ageing/afae248 ↗Auf einen Blick
In 1.664 Stationen aus 44 Ländern wurde die dokumentierte Delirprävalenz an zwei Tageszeitpunkten erhoben. Etwa jede:r fünfte Patient:in war delirant.
Fragestellung
Wie hoch ist die global dokumentierte Delirprävalenz und welche delirbezogenen Versorgungspraktiken werden auf Stationen berichtet?
Methode
Prospektive Querschnitts-Umfrage mit 39 Fragen; Erhebung am World Delirium Awareness Day, 15. März 2023.
Ergebnisse
1.664 Stationen aus 44 Ländern. Delir positiv um 8:00 Uhr bei 18 % (n = 2788/15 458) und um 8:00 p.m. bei 17,7 % (n = 2454/13 860). 61 % nutzten validierte Assessments.
Schlussfolgerung der Autor:innen
Etwa jede fünfte Patient:in wurde als delirant berichtet. Der hohe Einsatz von Benzodiazepinen erfordert weitere Bewertung und entspricht laut Autor:innen nicht den Best-Practice-Empfehlungen.
Kernaussagen
- Delirprävalenz: 18 % morgens und 17,7 % abends
- 61 % der Stationen nutzten validierte Delir-Assessments
- Häufige Barrieren: Personalmangel und fehlende Zeit für Schulung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Journal article in Age and Ageing, published online on 2024-11-20. Written by Heidi Lindroth and 22 co-authors. Institution: Department of Nursing, Division of Nursing Research, Mayo Clinic, Rochester, MN, USA. Major MEDLINE topics: Delirium. Cited 40 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY-NC 4.0).
Topics: Delir
Abstract (original language)
Background
Delirium, an acute brain dysfunction, is proposed to be highly prevalent in clinical care and shown to significantly increase the risk of mortality and dementia.
Objectives
To report on the global prevalence of clinically documented delirium and delirium-related clinical practices in wards caring for paediatric and adult patients in healthcare facilities.
Design
A prospective, cross-sectional, 39-question survey completed on World Delirium Awareness Day, 15 March 2023.
Participants
Clinicians or researchers with access to clinical data. Main Outcome and Measure The primary outcome was the prevalence of clinically documented delirium at 8:00 a.m. (4 h) and 8:00 p.m. (±4 h). Secondary outcomes included delirium-related care practices and barriers to use. Descriptive statistics were calculated and multilevel modelling was completed.
Results
1664 wards submitted surveys from 44 countries, reporting on delirium assessments at 8:00 a.m. (n = 36 048) and 8:00 p.m. (n = 32 867); 61% reported use of validated delirium assessment tools. At 8:00 a.m., 18% (n = 2788/15 458) and at 8:00 p.m., 17.7% (n = 2454/13 860) were delirium positive. Top prevention measures were pain management (86.7%), mobilisation (81.4%) and adequate fluids (80.4%). Frequently reported pharmacologic interventions were benzodiazepines (52.7%) and haloperidol (46.2%). Top barriers included the shortage of staff (54.3%), lack of time to educate staff (48.6%) and missing knowledge about delirium (38%). Conclusion and Relevance In this study, approximately one out of five patients were reported as delirious. The reported high use of benzodiazepines needs further evaluation as it is not aligned with best-practice recommendations. Findings provide a benchmark for future quality improvement projects and research.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Nursing, Division of Nursing Research, Mayo Clinic, Rochester, MN, USA.
- Center for Aging Research, Regenstrief Institute, Center for Health Innovation and Implementation Science, School of Medicine, Indiana University, Indianapolis, IN, USA.
- Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia.
- Institute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, Queensland, Australia.
- Non-Profit Organization ICU Collaboration Network (ICON), Tokyo, Japan.
- Family Medicine and Sports Medicine, University of South Florida, Morsani College of Medicine, USF Health, Tampa, FL, USA.
ORCID profiles: Mohan Gurjar, Peter Nydahl
Cite
APA
Lindroth, H., Liu, K., Szalacha, L., Ashkenazy, S., Bellelli, G., van den Boogaard, M., Caplan, G., Chung, C. R., Elhadi, M., Gurjar, M., Heras-La-Calle, G., Hoffman, M., Jeitziner, M. M., Krewulak, K., Mailhot, T., Morandi, A., Nawa, R. K., Oh, E. S., Collet, M. O., …, & WDAD Study Team (2024). World delirium awareness and quality survey in 2023—a worldwide point prevalence study. Age and Ageing, 53(11). https://doi.org/10.1093/ageing/afae248
Vancouver
Lindroth H, Liu K, Szalacha L, Ashkenazy S, Bellelli G, van den Boogaard M, et al. World delirium awareness and quality survey in 2023—a worldwide point prevalence study. Age and Ageing. 2024;53(11). doi:10.1093/ageing/afae248
BibTeX
@article{Lindroth2024,
author = {Lindroth, Heidi and Liu, Keibun and Szalacha, Laura and Ashkenazy, Shelly and Bellelli, Giuseppe and van den Boogaard, Mark and Caplan, Gideon and Chung, Chi Ryang and Elhadi, Muhammed and Gurjar, Mohan and Heras-La-Calle, Gabriel and Hoffman, Magdalena and Jeitziner, Marie-Madlen and Krewulak, Karla and Mailhot, Tanja and Morandi, Alessandro and Nawa, Ricardo Kenji and Oh, Esther S and Collet, Marie Oxenboell and Paulino, Maria Carolina and von Haken, Rebecca and Nydahl, Peter and WDAD Study Team, WDAD Study Team},
title = {World delirium awareness and quality survey in 2023—a worldwide point prevalence study},
journal = {Age and Ageing},
year = {2024},
volume = {53},
number = {11},
doi = {10.1093/ageing/afae248}
}
EUVIMED